Sonic Healthcare FY21 revenue +5% to $7.4bn and EBIT growth of 5%+ supports a forward yield of 3%.
FY21 EBITDA estimates, range from $1.5bn – $1.75bn.
You're not a member! Trial today
Buy Sonic within the $30 – $32 price range, as indicated below.
Posted on | by Leon Hinde
